Dimensional Fund Advisors LP Reports 5.1% Passive Stake in Pacira BioSciences Inc

On April 9, 2026, Dimensional Fund Advisors LP filed a Schedule 13G with the SEC, reporting a new 5.1% stake in Pacira BioSciences Inc (PCRX). As of the event date on March 31, 2026, the investment adviser beneficially owns 2,060,597 shares of common stock. Dimensional Fund Advisors LP serves as an investment manager, adviser, or sub-adviser to various registered investment companies, trusts, and separate accounts (collectively, the 'Funds'). While Dimensional possesses voting and investment power over these securities, it expressly disclaims beneficial ownership of the shares, noting they are owned by the underlying Funds. The filing indicates that 2,007,437 shares are held with sole voting power, while the full 2,060,597 shares are held with sole dispositive power. The acquisition was made in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This filing marks an increase from a previously reported 0.0% position, establishing Dimensional as a significant institutional shareholder.